Advertisement

Document › Details
Reuters. (6/13/17). "News: BRIEF – Kiadis Pharma Raises EUR 5 mln in Private Placement".
![]() |
Organisation | Kiadis Pharma N.V. (Euronext: KDS) |
Group | Kiadis (Group) | |
Organisation 2 | Euronext Amsterdam N.V. | |
Group | Euronext (Group) | |
![]() |
Product | investment banking |
Product 2 | ATIR™ (Kiadis) | |
![]() |
Index term | Kiadis–SEVERAL: investment, 201706 private placement €5m w 746k new shares €6.7/share = 11% discount to institutioal investors |
Original document
accessed by [iito] on 2017-06-20
Record changed: 2023-06-05 |
Advertisement

More documents for Kiadis (Group)
- [1] SynOx Therapeutics Ltd.. (7/27/21). "Press Release: SynOx Therapeutics Strengthens Team with Appointment of Ton Logtenberg as Chairman and Ray Barlow as Chief Executive Officer". Dublin....
- [2] Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam....
- [3] Byondis B.V.. (8/19/20). "Press Release: Byondis Announces Appointment of Chief Financial Officer". Nijmegen....
- [4] Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam....
- [5] Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam....
- [6] Kiadis Pharma N.V.. (11/12/19). "Press Release: Kiadis Pharma Changes Strategy to Focus Solely on Development of Natural Killer (NK) Cell Therapeutics and Terminates Development of ATIR101". Amsterdam....
- [7] Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam....
- [8] Kiadis Pharma N.V.. (10/17/19). "Press Release: Kiadis Pharma Provides Regulatory Update on ATIR101". Amsterdam....
- [9] Kiadis Pharma N.V.. (9/10/19). "Press Release: Kiadis Pharma Announces Results for the Six Months Ended June 30, 2019". Amsterdam....
- [10] Kiadis Pharma N.V.. (8/19/19). "Press Release: Kiadis Pharma Announces Investor Events for September 2019". Amsterdam....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top